NORMAX CAPITAL K.B. (“NORMAX”) is a trust management company regulated under the laws of the Kingdom of Sweden, duly registered with Bolagsverket under company number 969798-7692 and authorised to carry out fiduciary and financial management activities under applicable Swedish legislation, including the Trust and Trustees Act and Financial Instruments Trading Act. NORMAX operates within a closed-loop trust and asset management framework and is not a credit institution, bank, or publicly listed financial intermediary.
Where applicable, investment vehicles promoted by NORMAX may be structured as private placement opportunities, trust-linked tokenised products, or alternative investment offerings. Such Offerings are strictly limited to qualifying investors as defined under the relevant laws of Sweden, the European Union (including the AIFMD directive where applicable), and local jurisdictions where NORMAX operates through registered affiliates or representation offices.
Unless expressly stated otherwise, none of the securities, structured products, or tokenised instruments referred to on this Site or through any communications by NORMAX or its representatives constitute a public offering within the meaning of Regulation (EU) 2017/1129 (“Prospectus Regulation”), nor do they require the publication of a prospectus as defined therein.
All Offerings are made strictly by private invitation, through restricted or professional investor channels, and subject to formal acceptance and investor qualification procedures. Any investment documentation, including Private Placement Memoranda, Subscription Agreements or Token Purchase Terms, are made available exclusively to eligible and pre-vetted investors in jurisdictions where such Offerings are lawful and in compliance with applicable financial promotion regulations.
NORMAX Offerings are not available to the general public and may not be marketed, offered, or sold in jurisdictions where such activity would be unlawful or would require prior registration, licensing, or regulatory approval. Specifically, Offerings may not be made available in the United States, Canada, or any other jurisdiction subject to sanctions, prohibitions, or material regulatory restrictions, unless an applicable exemption applies.
Potential investors are solely responsible for ensuring that their participation in any Offering does not contravene local laws or regulatory requirements in their country of residence or citizenship. NORMAX disclaims any liability for the breach of securities laws by investors acting contrary to such restrictions.
Where applicable, NORMAX may offer access to investment structures utilising blockchain-based tokenisation technologies, including but not limited to ERC-20 compliant tokens representing fractional economic interests in real-world assets. These tokens do not constitute legal title, voting rights, or equity securities unless explicitly stated and governed by applicable contractual and trust-based legal frameworks.
Token holders participate in trust-based economic arrangements and are subject to the terms of the respective token issuance agreement, trust deed, and smart contract logic. These instruments are not listed on public cryptocurrency exchanges and may not offer secondary market liquidity.
Such products may be considered high-risk and speculative in nature. No guarantee is made as to the transferability, market value, or future regulatory treatment of blockchain-based instruments.
All investment opportunities offered by NORMAX involve a significant degree of financial risk, including but not limited to:
Investments in alternative asset classes, including tokenised artwork, real estate, energy infrastructure, mining rights, or private debt instruments, are inherently illiquid and not suitable for all investors. There can be no assurance that a profitable exit or return will be achieved within the stated investment horizon.
Investors must be prepared to bear the economic risk of investment for an extended period, which may exceed 36–60 months depending on the Offering.
Past performance of similar products, underlying asset classes, or illustrative indices referred to on this Site should not be relied upon as an indicator of future returns. Any forward-looking statements, financial projections, or hypothetical performance scenarios presented are based on assumptions that may not materialise and are subject to change without notice.
NORMAX does not guarantee the achievement of any target returns, capital appreciation, or income generation. Returns, if any, are conditional upon the performance of the underlying assets, market conditions, trust execution frameworks, and other factors beyond the control of NORMAX.
NORMAX and its affiliated entities may receive commissions, placement fees, performance-based compensation, or equity interests in connection with certain Offerings. Conflicts of interest may arise where NORMAX acts simultaneously as structurer, promoter, trustee, and/or token issuer.
Detailed information regarding fee structures, conflicts of interest, and any associated third-party service providers is provided in the respective investment documentation. Investors should review these disclosures carefully before participating.
Unless a formal client relationship has been established via a signed investment agreement, NORMAX owes no fiduciary duty or responsibility to website visitors, prospective investors, or parties expressing preliminary interest. The information presented does not create a relationship of reliance or obligation on the part of NORMAX, and must not be interpreted as personal investment advice.
NORMAX CAPITAL K.B. operates in conjunction with its registered subsidiaries, special purpose vehicles, and international representation offices, including but not limited to:
Each entity operates within its jurisdiction under its respective regulatory scope. Investors are advised to confirm the contracting party and the governing jurisdiction prior to engagement.
Any questions regarding the regulatory status of NORMAX, its licensing, or the authorisation of a specific Offering should be addressed to:
NORMAX CAPITAL K.B. – Compliance Department
Stockholms Brevboxar 145, 116 74, Stockholm, Sweden
Email: compliance@normaxcapital.com
Telephone: +46 8 519 72 416
